Imaging the Lungs of People With Cystic Fibrosis or Bronchiectasis
Studies lung imaging in people with cystic fibrosis or non-CF bronchiectasis, using xenon gas.
Key facts
- Who runs it
- Children's Hospital Medical Center, Cincinnati
- Where
- Cincinnati, United StatesSee the site
- Trial code
- Registry title
- Regional Phenotyping of CF and Non-CF Bronchiectasis
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 8 Feb 2021
- Expected to end
- 31 Dec 2028
- Type of study
- Observational, 2 groups
- Treatments tested
- Xenon
- Record updated
- 7 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and adults with cystic fibrosis, and also healthy people with no known heart or lung disease. All must be at least 5 years old.
- Age
- From 5 years to 100 years
- Sex
- All sexes can join
- Disease stage
- Cystic fibrosis confirmed by sweat chloride above 60 mMol/l. No stage or severity is stated.
- Biomarker or test result
- Two disease-causing CFTR mutations, or signs of the disease in other organs.
Main reasons for not taking part
- Cannot have an MRI scan (for example metal implants that are not MRI-compatible, or claustrophobia)
- Pregnancy
- Breastfeeding
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- CF Patients: Diagnosis of CF based on sweat chloride >60 mMol/l
- Presence of two disease causing CFTR mutations, or end organ manifestations of disease
- Age minimum 5 years
- Care provided by the CCHMC CF Care Center or other regional CF Care Centers if required to achieve recruitment goals
- Subjects 5 years of age and older with no known history of cardiopulmonary disease
Who cannot take part
- Patients meeting standard MRI exclusions criteria (non-MRI-compatible metal implants, claustrophobia, etc.)
- Patients meeting standard MRI exclusions criteria (non-MRI-compatible metal implants, claustrophobia, etc.)
- Pregnancy or lactation
- Pregnancy or lactation
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 5 and 100 years old?
Where in United States
- Penny NewCincinnati, United StatesContact: Penny A New, BBATaking people
About the trial
What the trial wants to find out
The Investigators propose to study pediatric subjects who are diagnosed with cystic fibrosis (CF) and patients with non-CF bronchiectasis, with the goal of developing markers of CF lung disease severity, progression, and therapy response. The Investigator's central hypothesis is that image-based markers can forecast pathophysiology prior to spirometric changes.
The 2 groups in the trial
- CF and Non-CF Bronchiectasis
In the first arm (Aims 1 \& 2) Up to 50 subjects will be recruited-approximately 25 with normal FEV1 (\>85% predicted) and 25 with mild to moderate disease. All subjects will be asked to undergo longitudinal (i.e., approximately annually) 129Xe and UTE MRI, spirometry, and lung clearance index (LCI) measurement.
Treatment: Xenon
- Healthy Subjects
Up to 50 age and sex matched control subjects (i.e., subjects with no known cardiopulmonary disorders) may also be recruited to provide a reference data set from healthy subjects for comparison.
Treatment: Xenon
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Regional Phenotyping of Cystic Fibrosis Lung Disease and Non-CF Bronchiectasis
- Plain-language title
- Imaging the Lungs of People With Cystic Fibrosis or BronchiectasisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04793867, who can take part
- Record updated
- 7 October 2026